Livongo Is Rocking Wall Street!

Livongo Glucose Monitor Reimagined

Livongo offers cloud based glucose monitoring to its patients with diabetes, selling it’s services directly to more than 600 employer-sponsored health plans. And ensurers at between $60.00 and $70.00 a month per employee. The company has also moved into treatments of cardiovascular diseases, weight loss and mental health. The question is as (Dr. Robert Huckman) a professor at Harvard business school who runs his health care initiative stated : for Livongo, and other health care start up to succeed , they must become indispensable for employees and insurance plans seeking to help patients manage their health. He continues..”what they most want is a single solution for any array of conditions their employees face”.

Can Livongo live up the expectations of investors?

Dr. Robert Watcher, professor and chairman at the Medicine department at University Of California in San Francisco, Say that Doctors are weary of using new technology, and they have been looking for a long time a better way to keep tabs on a patients health between office visits. However, according to the Wall Street Journal, Livongo is preparing for an initial public offering as soon as the third quarter of 2019 joining a base of technology companies racing to tap the public markets. The digital health start up has hired Morgan Stanley as underwriters for an IPO that is expected to value the company in excess of $1 billion. Livongo has raised nearly #240.00 million privately, most recently at an $800 million valuation.

Can Livongo Survive Competition and Industry Trends?

While Livongos IP will be smaller than those of high profile tech companies like: Uber technologies and Lyft Inc, silicon valley venture capital firms, bankers, public investors, and many of us will be watching closely. Livongo is set to be one of the first silicon valley companies to debut, that deploys technology in an effort to change how patients receive care and lower health care costs. Although, a lot of smaller private venture backed companies are jockering to provide similar services, but no one has achieve there venue or user base of Livongo, which is on track to take in more than 100 million this year from more than 120,000 patients. Livongo expects to more than double its revenue in 2020, people familiar with their financials said. Like most fast growing technology start ups, the company is still losing money as it pushes to grow its user base.

Conclusion:

Unlike for example the taxi or hotel industry, which have experience major overhauls as a result of technology disruption, health care so far has proved more resistance to change. The highly complex web of contracts, regulations, drug benefit managers and others make it hard for new entrants, to make inroads. Or we can just mentioned the failure of Google’s attempt to create an electronic health records data base in 2011 just three years after it began. I am sure we will be making a second story on LIVONGO HEALTH, in the near future, and go from there.

ps-need to grow your company? check our new free “post a job” section and start recruiting, post position and company’s name, and you all set!.

Jose Fuentes/ JFZ chief editor and founder